You are viewing a free limited preview of Sangart, Inc.
For Full Access: Unlock This Company Report For $99 or Upgrade To PrivCo Premium Subscription For Full Site-Wide Access

Sangart, Inc.

Private Company Ticker Symbol™: (SANGP)

Business Summary

Sangart, Inc. is a privately-held, venture capital backed biopharmaceutical company that engages in the research and development of oxygen therapeutics. It also offers Hemospan, a human hemoglobin-based product that delivers oxygen to tissues at risk of oxygen deprivation. Founded in 1998, Sangart, Inc. is headquartered in San Diego, California.

Overview & Corporate Organization

Basic Information

Company Tags:VC Backed
Year Founded:1998
Fiscal Year End:12/31
City:San Diego
State/Province:California
Country:United States
Phone:View
Website:www.sangart.com

Industry Information

Industry Codes

PICS™:1500107
NAICS:View
SIC:View

PrivCo Industries (Sector > Industry > Sub-Industry)

Technology > Biotechnology > Biotherapeutics

The PrivCo Industry Classification System™ (PICS) is our proprietary, modernized industry classification system, geared especially toward privately-held companies and including newer emerging sub-industries that are not reflected in other outdated industry classification systems, such as SIC and NAICS.

VC/Funding Activity

PrivCo's VC/Funding Activity table for Sangart, Inc. displays the venture capital rounds, angel investments, debt or other funding raised by Sangart, Inc..
All data before 2006 is completely free to view! To access data from 2006 onward:
Get Full Access To This Report Now! $99 Single Company Access
 
or Upgrade to PrivCo Premium Subscription Instant Full Site-Wide Access
Currently 50% Off Until May. 31!
DateInvestorRoundInvestor Type
UnspecifiedViewUnspecified
DetailsTotal Round Unspecified View
Feb. 2002UndisclosedC
DetailsTotal Round C $4,000,000
Aug. 2003Robert WinslowVenture FinancingAngel / Individual
Aug. 2003Norden Odin FonderVenture FinancingAngel / Individual
Aug. 2003Skandia LivforsakringaktiebolagetVenture FinancingAngel / Individual
Aug. 2003Banco HumanfondenVenture FinancingOther Investment Firm
Aug. 2003Gambro ABVenture FinancingCorporate
DetailsTotal Round Venture Financing $29,950,000
Oct. 2004Leucadia National Corp.DCorporate
Oct. 2004Life Equity Sweden KBDCorporate
Oct. 2004Gambro ABDCorporate
Oct. 2004UndisclosedD
DetailsTotal Round D $15,552,237
Aug. 2006ViewECorporate
Aug. 2006ViewECorporate
Aug. 2006ViewECorporate
Aug. 2006ViewE
DetailsTotal Round E View
Mar. 2007ViewOther
DetailsTotal Round Other View
Oct. 2010ViewOther
Oct. 2010ViewOtherCorporate
DetailsTotal Round Other View
Apr. 2011ViewGCorporate
Apr. 2011ViewGVenture Capital
DetailsTotal Round G View
May. 2012ViewGCorporate
DetailsTotal Round G2 View
Total of Funding Shown Above View
Notes
121 accredited...Read More →
2Funding was made upon the...Read More →
Full-length notes are available with Single Report Access or PrivCo Premium Subscription.

Missing a deal? Tell us about it! tips@privco.com

Supplemental Resources

For additional information on Sangart, Inc., you can see the following:

You are viewing a free limited preview of Sangart, Inc.
For Full Access: Unlock This Company Report For $99 or Upgrade To PrivCo Premium Subscription For Full Site-Wide Access